ClinicalTrials.Veeva

Menu

Metabolic Study of Cockayne Syndrome (METABO-CS)

U

University Hospital, Strasbourg, France

Status

Terminated

Conditions

Cockayne Syndrome

Treatments

Other: Metabolic evaluation

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Cockayne syndrome (CS) is related to defective DNA transcription and/or repair and belongs to the family of Nucleotide Excision Repair. It is an autosomal recessive multisystemic disorder characterized by mental retardation, microcephaly, severe growth failure with lipoatrophia, sensorial impairment, cutaneous photosensitivity, dental decay, enophtalmios. The disease is progressive causing severe impairments but there's currently no therapeutics for the disease.

Growth failure, feeding difficulties and lipoatrophia are prognostic keys of CS but physiopathology is unknown.

According to preliminary assays, our goal is to test the hypothesis that cachexia is due to hypometabolism. We also want to test the potential link between this basal metabolism modification and mitochondrial dysfunction and somatotrope axis, and correlation between the basal metabolism degree and global severity of the disease.

Enrollment

25 patients

Sex

All

Ages

6+ months old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Cockayne patients:

Inclusion criteria :

  • Male and female with cockayne syndrome
  • Age>6 months

Exclusion criteria:

  • Intercurrent diseases
  • Subject in period of exclusion
  • Pregnancy and breastfeeding

Control subjects :

Inclusion criteria :

  • Sister or brother of Cockayne patients
  • Age>6 months

Exclusion criteria:

  • Intercurrent diseases
  • Subject in periods of exclusion
  • Pregnancy and breastfeeding

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

25 participants in 2 patient groups

Cockayne patients
Other group
Description:
Interventions performed: * blood sample * urinary collection * metabolic evaluation * clinical evaluation
Treatment:
Other: Metabolic evaluation
Control subjects
Other group
Description:
Interventions performed: * urinary collection * metabolic evaluation * clinical evaluation
Treatment:
Other: Metabolic evaluation

Trial contacts and locations

1

Loading...

Central trial contact

Vincent LAUGEL, MD, PhD; Marie-Aude SPITZ, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems